ArticleThe lancet. Diabetes & endocrinology2020

Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?

Hillel K Sternlicht et al.PubMed ↗Publisher ↗

No numbers read from the abstract.